Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Fisher Scientific AS
AS
Active
Org 940354137
Ullernchausséen 52, 0379
Oslo
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1986 · 40 years old
11 employees
Monitor
Share
Norway
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Fisher Scientific AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
144M
108M
72M
36M
0M
2021: 92M
92M
2021
2022: 103M (+12% vs 2021)
103M
+12%
2022
2023: 111M (+8% vs 2022)
111M
+8%
2023
2024: 116M (+5% vs 2023)
116M
+5%
2024
2025: 115M (-1% vs 2024)
115M
-1%
2025
EBITDA
NOK millions
5M
4M
2M
1M
0M
2021: 3M
3M
2021
2022: 3M (0% vs 2021)
3M
0%
2022
2023: 3M (0% vs 2022)
3M
0%
2023
2024: 2M (-33% vs 2023)
2M
-33%
2024
2025: 4M (+100% vs 2024)
4M
+100%
2025
Income statement
NOK thousands
Item
2025
2024
2023
2022
2021
Revenue
115 262
116 165
110 679
102 679
92 276
Staff expenses
−0
−0
−0
−1 865
−1 920
EBITDA
4 045
2 125
3 130
2 825
3 217
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
4 045
2 125
3 130
2 825
3 217
Net financials
154
820
263
−0
85
Profit before tax
4 199
2 945
3 393
2 825
3 302
Tax
−0
−0
−0
−6 939
−0
Net profit
3 262
2 252
2 627
9 765
3 302
Balance sheet
NOK thousands
Item
2025
2024
2023
2022
2021
Total assets
57 778
54 277
46 911
49 773
35 044
Equity
36 681
33 419
31 167
28 540
18 776
Long-term debt
0
0
0
0
0
Short-term debt
21 097
20 857
15 744
21 232
16 268
Total debt
21 097
20 857
15 744
21 232
16 268
Financial ratios
5-year trend
EBITDA margin
3,5 %
This company
15,8 %
Market median
This company
Market median
78% below market
2021
2025
Equity ratio
63,5 %
This company
38,2 %
Market median
This company
Market median
66% above market
2021
2025
Return on equity
8,9 %
This company
18,4 %
Market median
This company
Market median
52% below market
2021
2025
Net profit margin
2,8 %
This company
8,1 %
Market median
This company
Market median
65% below market
2021
2025
Asset turnover
1,99×
This company
1,12×
Market median
This company
Market median
78% above market
2021
2025
Debt / equity
0,58×
This company
0,62×
Market median
This company
Market median
6% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
More on Fisher Scientific AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
